CQP(SZ:000950)2023-03-22 10:32Group 1: Company Overview - Chongqing Pharmaceutical Holdings is a large modern pharmaceutical distribution enterprise serving the entire pharmaceutical industry chain, involved in pharmaceutical research and development, medical device production, and investment in pharmaceutical industry collaboration [2][3] - The company operates under the Chongqing Pharmaceutical (Group) Co., Ltd., established in 1950, and is one of the few national wholesale enterprises for anesthetics and first-class psychotropic drugs in China [2][3] Group 2: Strategic Planning - The company's 14th Five-Year Plan aims for high-quality development, targeting sales exceeding 100 billion yuan by 2025, with a focus on "internal growth and external expansion" [3] - The strategic goal includes establishing a presence in 300 prefecture-level cities and enhancing capabilities in marketing, supply chain, IT, and auxiliary diagnosis [3] Group 3: Business Model Advantages - The integrated wholesale and retail model reduces operational costs and enhances supply chain advantages, facilitating the introduction of various drug categories into retail channels [3][4] - The company has established over 100 specialized pharmacies nationwide, promoting a new business model for prescription drug sales through internet hospitals [4] Group 4: Mergers and Acquisitions - The company's mergers and acquisitions during the 13th Five-Year Plan have expanded its national network and increased profitability, with profits from outside Chongqing rising from approximately 35% in 2018 to about 60% by 2021 [4] Group 5: Logistics and Supply Chain - The company boasts an advanced logistics distribution system, focusing on pharmaceutical supply chain services, with multiple distribution centers established in various provinces [4][5] - Chongqing Pharmaceutical Group's logistics subsidiary aims to create the largest third-party distribution and pharmaceutical logistics business in the western region [5]